• Users Online: 302
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs

Sriwijitalai Won, Wiwanitkit Viroj

Year : 2019| Volume: 3| Issue : 2 | Page no: 101-104

   This article has been cited by
 
1 Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies
Candice Soares de Melo,Vinayak Singh,Alissa Myrick,Sandile B. Simelane,Dale Taylor,Christel Brunschwig,Nina Lawrence,Dirk Schnappinger,Curtis A. Engelhart,Anuradha Kumar,Tanya Parish,Qin Su,Timothy G. Myers,Helena I. M. Boshoff,Clifton E. Barry,Frederick A. Sirgel,Paul D. van Helden,Kirsteen I. Buchanan,Tracy Bayliss,Simon R. Green,Peter C. Ray,Paul G. Wyatt,Gregory S. Basarab,Charles J. Eyermann,Kelly Chibale,Sandeep R. Ghorpade
Journal of Medicinal Chemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis
BibieN Said, ScottK Heysell, Getnet Yimer, RobE Aarnoutse, GibsonS Kibiki, Stellah Mpagama, PeterM Mbelele
International Journal of Mycobacteriology. 2021; 10(4): 457
[Pubmed]  [Google Scholar] [DOI]

 

Read this article